Description
A dual inhibitor of PKC and SPHK; inhibits PKC by binding at the regulatory phorbol-binding domain (IC50 = 24 µM); inhibits SPHK (Ki = ~5 µM); restores sensitivity to cisplatin in resistant AGScis5 cells and N87 gastric cancer cells from 0.2-6 µM
Formal name: (2S,3S)-2-amino1,3-octadecanediol
Synonyms: L-threo-Dihydrosphingosine|L-threo-Sphinganine
Molecular weight: 301.5
CAS: 15639-50-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Lipid Kinases||Product Type|Biochemicals|Kinase Inhibitors|PKC||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Sphingolipid Turnover||Research Area|Cancer|Cell Signaling|PKC Signaling||Research Area|Lipid Biochemistry|Sphingolipids